HOME >> BIOLOGY >> NEWS
Chromosome deletion predicts aggressive neuroblastoma

When genes are deleted on a particular section of chromosome 11, the result is an aggressive form of the childhood cancer neuroblastoma. A new study suggests that detecting this genetic deletion during the initial evaluation of children with neuroblastoma may indicate to physicians that they should recommend a more aggressive regimen of chemotherapy to fight the cancer.

Edward F. Attiyeh, M.D., a pediatric oncology fellow at The Children's Hospital of Philadelphia, reported on a study of 915 patients in a presentation today at the American Society of Clinical Oncology annual meeting in Orlando, Fla. The patients were children with primary neuroblastoma treated at Children's Oncology Group (COG) centers. The COG is a National Institutes of Health-funded multicenter clinical research organization that supports clinical trials for pediatric cancer patients.

Neuroblastoma, which accounts for 10 percent of all pediatric cancers, often occurs as a solid tumor in a child's abdomen or chest. Some cases of neuroblastoma are low risk, and resolve after surgeons remove the tumor. Other cases are more aggressive, and are more likely to resist initial treatment, or to cause a relapse. Identifying the correct risk level allows doctors to treat aggressive cancers appropriately, while not subjecting children with low-risk cancer to overtreatment.

Oncologists know that amplification, an abnormal increase in the number of copies, of a cancer-causing gene called MYCN heralds a high-risk, aggressive cancer. However, a significant number of neuroblastomas are aggressive without having amplified MYCN. "The deletion of genetic material on chromosome 11 may account for a significant percentage of these high-risk neuroblastomas," said Dr. Attiyeh.

It is unknown what causes the deletion of genes on chromosome 11, at a location designated chromosome 11q23. However, the loss of material at that site apparently removes the protective effect of a tumor suppress
'"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
16-May-2005


Page: 1 2

Related biology news :

1. Chromosome glue repairs damaged DNA
2. Chromosome rearrangements not as random as believed
3. Chromosome regions containing genes related to alcohol addiction affect drinking behavior in smokers
4. Chromosome four contains genes that affect drinking behaviors in smokers
5. Chromosome 16 publication fulfills DOEs human genome commitment
6. Teens with deletion syndrome confirm genes role in psychosis
7. Gene predicts better outcome as cortex normalizes in teens with ADHD
8. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
9. Major study predicts grim future for Europes seas
10. FDG-PET imaging clearly predicts lung cancer patients response to chemotherapy
11. NASA predicts nongreen plants on other planets

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 16, 2019 , ... uBiome, the leader ... platform that uses artificial intelligence (AI) and a data-centric approach to decentralize medicine ... ulcerative colitis. , People will Crohn’s or other chronic medical conditions join a ...
(Date:1/14/2019)... ... January 14, 2019 , ... Join the live session ... about key topics in data quality, including:, ,     State of ... ,     Smartphone and wearable based performance measures ,     Data quality analytics ...
(Date:1/8/2019)... (PRWEB) , ... January 07, 2019 , ... ... and compliance solutions, is proud to welcome Thomas Kennedy as head of sales ... Miglicco, CEO for PureWay. , Mr. Kennedy has previously worked for Johnson & ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... ... January 11, 2019 , ... ... for the automated collection of donor blood. This advanced and intuitive medical ... The unit incorporates the functionality needed for the busiest donor stations with new-to-the ...
(Date:1/10/2019)... ... ... adopted from a local shelter when he was around two years old. According to ... after he was adopted, he tore his right cruciate ligament. Though he had his ... a traumatic injury. , Sure enough, when Rascal was about nine years old, he began ...
(Date:1/10/2019)... ... January 08, 2019 , ... VGI Medical was founded in ... leader in bringing innovation to the market including VerteLoc, CerLoc, SiJoin and VerteLP. The ... by utilizing a unique patented dual geometric design to limit motion of the affected ...
(Date:1/8/2019)... ... January 08, 2019 , ... The American Society of Gene and Cell ... a selection committee made up of industry leaders identified by the ASGCT board of ... mentored awards created to support ASGCT members designing transformative pilot studies in gene and ...
Breaking Biology Technology:
Cached News: